European regulator says there is a ‘link’ between AstraZeneca vaccine and blood clots
Those reports led to a temporary pause in the use of the jabs in Ireland, but the vaccine is now back on stream.
The decision to continue to use the vaccine despite an investigation to determine whether it did cause blood clots, came following advice from the EMA that the positives of the vaccine outweigh the negatives.
There had already been a restriction on the use of the AstraZeneca jab for people over the age of 70, but the National Immunisation Advisory Council since said that the vaccine could be used for patients above that age.
There have since been reports that the use of the vaccine could be restricted for younger recipients based off EMA research.
Its head of vaccines, Marco Cavaleri, has now told Italy’s Il Messaggero newspaper that the EMA will announce that there is a link soon.
‘We are trying to get a precise picture of what is happening, to define in detail this syndrome due to the vaccine.
‘Among the vaccinated, there are more cases of cerebral thrombosis … among young people than we would expect.’